Atlas Trials

A Study of ALKS 3831 in Adults With Schizophrenia

Clinical trial NCT01903837 · COMPLETED

Trial details

NCT number
NCT01903837
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2013-06-01
Primary completion
2014-12-01
Enrollment
347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.